ClinicalTrials.gov
ClinicalTrials.gov Menu

Study to Assess the Safety of Escalating Doses of AT13387 in Patients With Metastatic Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00878423
Recruitment Status : Completed
First Posted : April 9, 2009
Last Update Posted : May 8, 2014
Sponsor:
Information provided by (Responsible Party):
Astex Pharmaceuticals

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : May 2013
  Actual Study Completion Date : March 2014